Literature DB >> 1657190

Lipid metabolism in T47D human breast cancer cells: 31P and 13C-NMR studies of choline and ethanolamine uptake.

S M Ronen1, E Rushkin, H Degani.   

Abstract

31P and 13C-NMR were used to determine the kinetics of choline and ethanolamine incorporation in T47D clone 11 human breast cancer cells grown as small (150 microns) spheroids. Spheroids were perfused inside the spectrometer with 1,2-13C-labeled choline or 1,2-13C-labeled ethanolamine (0.028 mM) and the buildup of labeled phosphoryl-choline (PC) or phosphorylethanolamine (PE) was monitored. Alternatively the PC and GPC pools were prelabeled with 13C and the reduction of label was monitored. 31P spectra were recorded from which the overall energetic status as well as total pool sizes could be determined. The ATP content was 8 +/- 1 fmol/cell, and the total PC and PE pool sizes were 16 and 14 fmol/cell, respectively. PC either increased by 50% over 24 h or remained constant, while PE remained constant in medium without added ethanolamine but increased 2-fold within 30 h in medium containing ethanolamine, indicating a dependence on precursor concentration in the medium. The 31P and 13C data yielded similar kinetic results: the rate of the enzymes phosphocholine kinase and phosphoethanolamine kinase were both on the order of 1.0 fmol/cell per h, and the rate constants for CTP:phosphocholine cytidyltransferase and CTP:phosphoethanolamine kinase were 0.06 h-1 for both enzymes. The kinetics of choline incorporation did not alter in the presence of 0.028 mM ethanolamine indicating that they have non-competing pathways.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657190     DOI: 10.1016/0167-4889(91)90038-y

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Kinetic analysis of hyaluronidase activity using a bioactive MRI contrast agent.

Authors:  Liora Shiftan; Michal Neeman
Journal:  Contrast Media Mol Imaging       Date:  2006 May-Jun       Impact factor: 3.161

Review 2.  MRI and MRS of intact perfused cancer cell metabolism, invasion, and stromal cell interactions.

Authors:  Marie-France Penet; Tariq Shah; Flonne Wildes; Balaji Krishnamachary; Santosh K Bharti; Jesus Pacheco-Torres; Dmitri Artemov; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2019-01-28       Impact factor: 4.044

3.  Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy.

Authors:  Christopher S Ward; Humsa S Venkatesh; Myriam M Chaumeil; Alissa H Brandes; Mark Vancriekinge; Hagit Dafni; Subramaniam Sukumar; Sarah J Nelson; Daniel B Vigneron; John Kurhanewicz; C David James; Daphne A Haas-Kogan; Sabrina M Ronen
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

4.  Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma.

Authors:  Humsa S Venkatesh; Myriam M Chaumeil; Christopher S Ward; Daphne A Haas-Kogan; C David James; Sabrina M Ronen
Journal:  Neuro Oncol       Date:  2011-12-12       Impact factor: 12.300

Review 5.  MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.

Authors:  Kristine Glunde; Lu Jiang; Siver A Moestue; Ingrid S Gribbestad
Journal:  NMR Biomed       Date:  2011-07       Impact factor: 4.044

6.  Hyperpolarized 13C spectroscopic imaging informs on hypoxia-inducible factor-1 and myc activity downstream of platelet-derived growth factor receptor.

Authors:  Hagit Dafni; Peder E Z Larson; Simon Hu; Hikari A I Yoshihara; Christopher S Ward; Humsa S Venkatesh; Chunsheng Wang; Xiaoliang Zhang; Daniel B Vigneron; Sabrina M Ronen
Journal:  Cancer Res       Date:  2010-09-21       Impact factor: 12.701

7.  Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells.

Authors:  Alessia Lodi; Sarah M Woods; Sabrina M Ronen
Journal:  NMR Biomed       Date:  2012-09-03       Impact factor: 4.044

8.  MR-detectable metabolic consequences of mitogen-activated protein kinase kinase (MEK) inhibition.

Authors:  Alessia Lodi; Sarah M Woods; Sabrina M Ronen
Journal:  NMR Biomed       Date:  2014-04-02       Impact factor: 4.044

Review 9.  Metabolism of breast cancer cells as revealed by non-invasive magnetic resonance spectroscopy studies.

Authors:  O Kaplan; J S Cohen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.

Authors:  Alissa H Brandes; Christopher S Ward; Sabrina M Ronen
Journal:  Breast Cancer Res       Date:  2010-10-14       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.